| Application no. and date | 18734135.9 (espacenet) (Federated) (European Patent Register), 20180615 | | Patent/reg. no. and date | DK/EP 3638291, 20210818 | | Publication date | 20200422 | | Priority no. and date | GB 201709643, 20170616, GB 201714203, 20170905, GB 201800873, 20180119 | | EP pub. no. and date |
EP 3638291 20200422 | | Effective date | | | Applicant/owner | ZEALAND PHARMA A/S, Sydmarken 11, 2860 Søborg, DK | | Applicant ref. no. | V349413DK00 | | Inventor | SONNE, Kim, c/o Zealand Pharma A/S
Smedeland 36, 2600 Glostrup, DK,
MOURITZEN, Ulrik, c/o Zealand Pharma A/S
Smededland 36, 2600 Glostrup, DK,
GLERUP, Peter, c/o Zealand Pharma A/S
Smedeland 36, 2600 Glostrup, DK,
JEPPESEN, Palle Bekker, Ellebækvej 32, 2820 Gentofte, DK | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61P 1/00 (2006.01) | | Title | Dosisregimer til indgivelse af glucagon-lignende-peptid-2 (GLP-2)-analoger | | Int. application no. | EP2018065951 | | Int. publication no. | WO2018229252 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
